Results 271 to 280 of about 538,972 (311)

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur   +7 more
wiley   +1 more source

Preterm meconium‐stained amniotic fluid: A red flag for infection and adverse perinatal outcomes

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Meconium‐stained amniotic fluid (MSAF) is uncommon in preterm deliveries and raises concerns about maternal and neonatal infectious risks. We aimed to evaluate maternal, perinatal, and microbiological outcomes in preterm deliveries complicated by MSAF compared to clear amniotic fluid (AF) and to assess outcomes in preterm versus term
Raneen Abu Shqara   +3 more
wiley   +1 more source

Preconceptual care reduces risk of spontaneous preterm birth for select high‐risk populations: A prospective study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Prevention of preterm birth (PTB) is an urgent unmet clinical need. Preconceptual counseling for women at high‐risk of PTB offers a unique opportunity to mitigate risk of preterm birth for subsequent pregnancy. The present study aimed to examine the impact of preconceptual counseling on rates of PTB in a high‐risk population ...
Gillian A. Corbett   +7 more
wiley   +1 more source

Factors contributing to long‐term vaginal pessary use: A mixed‐methods study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective One of the treatment options in pelvic organ prolapse (POP) is vaginal pessary therapy. For a well‐informed decision, different aspects of the treatment option, including sustainable long‐term outcomes, need to be discussed with the patient.
L. E. Drost   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy